Comparative in vitro activity of BAY Y 3118 against selected species. - Suppr | 超能文献

Comparative in vitro activity of BAY Y 3118 against selected species.

作者信息

Verbist L, Verhaegen J

机构信息

Department of Bacteriology, University Hospital St Rafaël, Leuven, Belgium.

出版信息

Drugs. 1995;49 Suppl 2:264-5. doi: 10.2165/00003495-199500492-00064.

DOI:10.2165/00003495-199500492-00064

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Comparative in vitro activity of BAY Y 3118 against selected species.

Drugs. 1995;49 Suppl 2:264-5. doi: 10.2165/00003495-199500492-00064.

2

Comparative in vitro activity of BAY Y 3118 with other fluoroquinolones.BAY Y 3118与其他氟喹诺酮类药物的体外活性比较

Drugs. 1995;49 Suppl 2:222-5. doi: 10.2165/00003495-199500492-00048.

3

In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.新型二氟喹诺酮洛美沙星对尿液细菌分离株的体外活性：与依诺沙星和氧氟沙星的比较。

J Chemother. 1989 Jul;1(4 Suppl):176-7.

4

Comparative in vitro activities of new quinolones against coryneform bacteria.新型喹诺酮类药物对棒状杆菌的体外活性比较

Antimicrob Agents Chemother. 1994 Jun;38(6):1439-41. doi: 10.1128/AAC.38.6.1439.

5

In vitro susceptibility to ciprofloxacin of bacterial strains isolated from chronic otitis media and chronic sinusitis.从慢性中耳炎和慢性鼻窦炎分离出的细菌菌株对环丙沙星的体外敏感性。

Drugs. 1995;49 Suppl 2:200-2. doi: 10.2165/00003495-199500492-00041.

6

In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens.司帕沙星与环丙沙星及氧氟沙星相比对呼吸道病原体的体外活性。

Chemotherapy. 1993;39(1):32-5. doi: 10.1159/000238970.

7

A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.氟罗沙星与其他三种喹诺酮类药物体外活性比较的多中心研究：来自27个中心的中期报告

Am J Med. 1993 Mar 22;94(3A):2S-8S.

8

The new 4-quinolones DU-6859a and DV-7751a show enhanced activity against Streptococcus pneumoniae.新型4-喹诺酮类药物DU-6859a和DV-7751a对肺炎链球菌显示出增强的活性。

Drugs. 1995;49 Suppl 2:228-9. doi: 10.2165/00003495-199500492-00050.

9

[The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].[Maxaquin（盐酸洛美沙星）在治疗非特异性炎症性疾病及预防泌尿外科手术干预中的应用]

Urol Nefrol (Mosk). 1998 Sep-Oct(5):14-8.

10

In vitro activity of MF 5137, a new potent 6-aminoquinolone.

Drugs. 1995;49 Suppl 2:272-3. doi: 10.2165/00003495-199500492-00067.

本文引用的文献

1

In vitro activity of Bay y 3118, a new quinolone.新型喹诺酮类药物Bay y 3118的体外活性

Antimicrob Agents Chemother. 1993 Nov;37(11):2348-57. doi: 10.1128/AAC.37.11.2348.

2

In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections.BAY Y3118、环丙沙星、氧氟沙星和氟罗沙星对呼吸道及软组织感染的革兰氏阳性和革兰氏阴性病原体的体外活性。

Antimicrob Agents Chemother. 1993 Sep;37(9):2017-9. doi: 10.1128/AAC.37.9.2017.